AVB-500, a receptor tyrosine kinase AXL inhibitor, improves response to olaparib in uterine serous cancer.

被引：0
|
作者：
Toboni, Michael D. [1 ]
Mullen, Mary [1 ]
Tankou, Jo'an [1 ]
Noia, Hollie [1 ]
Oplt, Alyssa [1 ]
Wilke, Daniel [1 ]
Khabele, Dineo [1 ]
Kuroki, Lindsay [1 ]
Hagemann, Andrea [1 ]
McCourt, Carolyn [1 ]
Thaker, Premal [1 ]
Mutch, David [1 ]
Powell, Matthew [1 ]
Fuh, Katherine [1 ]
机构：
[1] Washington Univ, St Louis, MO 63110 USA
来源：
CLINICAL CANCER RESEARCH | 2021年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO047
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Author Correction: The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer
    Xun Hui Yeo
    Vignesh Sundararajan
    Zhengwei Wu
    Zi Jin Cheryl Phua
    Yin Ying Ho
    Kai Lay Esther Peh
    Yi-Chia Chiu
    Tuan Zea Tan
    Dennis Kappei
    Ying Swan Ho
    David Shao Peng Tan
    Wai Leong Tam
    Ruby Yun-Ju Huang
    Communications Biology, 6
  • [22] Suppression of breast cancer metastasis by R428, a novel small molecule inhibitor of the Axl receptor tyrosine kinase
    Holland, Sacha
    Franci, Christian
    Hu, Yuanming
    Pan, Alison
    Chang, Betty
    Li, Weiqun
    Duan, Matt
    Bagos, Arthur
    Torneros, Alian
    Zhang, Jing
    Yu, Jiaxin
    Ding, Pingyu
    Heckrodt, Thilo
    Apatira, Ayodele
    Lin, Din-Lii
    Lang, Wayne
    Chua, Joanne
    Brandt, Ralf
    Clemens, George
    Pine, Polly
    Goff, Dane
    Singh, Raj
    Payan, Donald
    Hitoshi, Yasumichi
    CANCER RESEARCH, 2009, 69
  • [23] Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer
    Xie, Yunong
    Wu, Haofeng
    He, Yimiao
    Liu, Linglin
    Huang, Ianto Bosheng
    Zhou, Lei
    Lin, Cheuk-Yin
    Leung, Rainbow Wing-Hei
    Loh, Jia-Jian
    Lee, Terence Kin-Wah
    Ding, Jin
    Man, Kwan
    Ma, Stephanie
    Tong, Man
    CELL DEATH & DISEASE, 2024, 15 (02)
  • [24] Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer
    Yunong Xie
    Haofeng Wu
    Yimiao He
    Linglin Liu
    Ianto Bosheng Huang
    Lei Zhou
    Cheuk-Yin Lin
    Rainbow Wing-Hei Leung
    Jia-Jian Loh
    Terence Kin-Wah Lee
    Jin Ding
    Kwan Man
    Stephanie Ma
    Man Tong
    Cell Death & Disease, 15
  • [25] The effect of inhibition of receptor tyrosine kinase AXL on DNA damage response in ovarian cancer (vol 6, 660, 2023)
    Yeo, Xun Hui
    Sundararajan, Vignesh
    Wu, Zhengwei
    Phua, Zi Jin Cheryl
    Ho, Yin Ying
    Peh, Kai Lay Esther
    Chiu, Yi-Chia
    Tan, Tuan Zea
    Kappei, Dennis
    Ho, Ying Swan
    Tan, David Shao Peng
    Tam, Wai Leong
    Huang, Ruby Yun-Ju
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [26] EKB-569: a new irreversible inhibitor of epidermal growth factor receptor tyrosine kinase for the treatment of cancer.
    Greenberger, LM
    Discafani, C
    Wang, YF
    Tsou, HR
    Overbeek, EG
    Nilakantan, R
    Frost, P
    Wissner, A
    CLINICAL CANCER RESEARCH, 2000, 6 : 4544S - 4544S
  • [27] WM-S1, the novel small molecule inhibitor of mutant RTK/receptor tyrosine kinase, for the treatment of cancer.
    Kim, Joseph
    Moon, Jai-Hee
    Lee, Kyung-Mi
    Ryu, Hyun
    Park, Eun Hye
    Kim, Sang Hee
    Kim, Jeong Seok
    Ko, Young Ok
    Kim, Yong Seok
    Kim, Hyo Jin
    Kim, Tae Young Kim
    Yoo, Moon Seong
    Jin, Soll
    Kim, Seongrak
    Park, Yoon Sun
    Lee, Min Ki
    Lee, Mi So
    Go, Ji Hyun
    Ji, Yu Geun
    Lee, Jun Hyung
    Lee, Haneul
    Kim, Min Hwa
    Ko, Eun Hee
    Lee, Yeo Jin
    Kim, Seung-Mi
    Jeong, Joon-yee
    Choi, Yeon-seoung
    Bae, Seung-geon
    Lee, Jinwoo
    Lee, Won Jun
    Kim, Min-Kyeong
    Shin, Ji Min
    Koh, Dong-in
    Hur, Sun-Chul
    Park, Chun-Ho
    Lee, Hyun Ho
    Jin, Dong-Hoon
    CANCER RESEARCH, 2022, 82 (12)
  • [28] Evaluation of the MET/AXL Receptor Tyrosine Kinase (RTK) Inhibitor MGCD265 in a Patient with Metastatic Non-Small Cell Lung Cancer (NSCLC) Harboring AXL Amplification
    Do, Khanh T.
    Macconaill, Laura
    Dubuc, Adrian
    Chen, Isan
    Chao, Richard
    Tassell, Vanessa
    Christensen, James
    Shapiro, Geoffrey I.
    Sholl, Lynette M.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S797 - S797
  • [29] Molecular predictors of response to combination chemotherapy with gefitinib (zd1839, EGFR tyrosine kinase inhibitor) for advanced colorectal cancer.
    Ogino, S
    Meyerhardt, J
    Cantor, M
    Brahmandam, M
    Ryan, D
    Namgyal, C
    Kawasaki, T
    Kinsella, K
    Enzinger, P
    Clark, J
    Kulke, M
    Loda, M
    Fuchs, C
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2005, 7 (05): : 682 - 682
  • [30] Effect of inhibition of receptor tyrosine kinase AXL by a selective small molecular inhibitor R428 (BGB321) on DNA damage repair response in ovarian cancer cells.
    Huang, Ruby Yun-Ju
    Yeo, Xun Hui
    Tam, Wai Leong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345